Blockage of TNF‐α, IL‐1, and IL‐6 has been shown to preserve the cardiac function, indicating targeting these inflammatory cytokines should be a potential therapeutic approach to treat MI.8, 9, 10, 11. This evidence concerns the gene IL1B and myocardial infarction.